U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Narrow nasal ridge

MedGen UID:
373404
Concept ID:
C1837761
Finding
Synonyms: Pinched nose; Thin nasal ridge
 
HPO: HP:0000418

Definition

Decreased width of the nasal ridge. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVNarrow nasal ridge

Conditions with this feature

Ehlers-Danlos syndrome, type 4
MedGen UID:
82790
Concept ID:
C0268338
Disease or Syndrome
Vascular Ehlers-Danlos syndrome (vEDS) is characterized by arterial, intestinal, and/or uterine fragility; thin, translucent skin; easy bruising; characteristic facial appearance (thin vermilion of the lips, micrognathia, narrow nose, prominent eyes); and an aged appearance to the extremities, particularly the hands. Vascular dissection or rupture, gastrointestinal perforation, or organ rupture are the presenting signs in most adults with vEDS. Arterial rupture may be preceded by aneurysm, arteriovenous fistulae, or dissection but also may occur spontaneously. The majority (60%) of individuals with vEDS who are diagnosed before age 18 years are identified because of a positive family history. Neonates may present with clubfoot, hip dislocation, limb deficiency, and/or amniotic bands. Approximately half of children tested for vEDS in the absence of a positive family history present with a major complication at an average age of 11 years. Four minor diagnostic features – distal joint hypermobility, easy bruising, thin skin, and clubfeet – are most often present in those children ascertained without a major complication.
Follicular atrophoderma and basal cell epitheliomata
MedGen UID:
87539
Concept ID:
C0346104
Neoplastic Process
Bazex-Dupre-Christol syndrome (BDCS) is an X-linked dominant disorder characterized by a triad of congenital hypotrichosis, follicular atrophoderma affecting the dorsa of the hands and feet, the face, and extensor surfaces of the elbows or knees, and the development of basal cell neoplasms, including basal cell nevi and basal cell carcinomas from the second decade onward (Yung and Newton-Bishop, 2005). Rombo syndrome (180730) has similar features, but shows autosomal dominant inheritance.
Neonatal pseudo-hydrocephalic progeroid syndrome
MedGen UID:
140806
Concept ID:
C0406586
Disease or Syndrome
Wiedemann-Rautenstrauch syndrome (WDRTS) is a rare autosomal recessive neonatal progeroid disorder characterized by intrauterine growth retardation, failure to thrive, short stature, a progeroid appearance, hypotonia, and variable mental impairment (summary by Toriello, 1990). Average survival in WDRTS is 7 months, although survival into the third decade of life has been reported (Akawi et al., 2013).
Mandibuloacral dysplasia with type B lipodystrophy
MedGen UID:
332940
Concept ID:
C1837756
Disease or Syndrome
Mandibuloacral dysplasia with type B lipodystrophy (MADB) is a rare autosomal recessive disorder characterized by postnatal growth retardation, craniofacial anomalies such as mandibular hypoplasia, skeletal anomalies such as progressive osteolysis of the terminal phalanges and clavicles, and skin changes such as mottled hyperpigmentation and atrophy. The lipodystrophy is characterized by generalized loss of subcutaneous fat involving the face, trunk, and extremities. Some patients have a progeroid appearance. Metabolic complications associated with insulin resistance have been reported (Schrander-Stumpel et al., 1992; summary by Simha et al., 2003). For a general phenotypic description of lipodystrophy associated with mandibuloacral dysplasia, see MADA (248370).
Large congenital melanocytic nevus
MedGen UID:
330752
Concept ID:
C1842036
Neoplastic Process
Congenital melanocytic nevus syndrome is characterized by pigmentary skin defects apparent at birth. Most individuals have 1 or more large or giant lesions greater than 20 cm and up to over 60 cm in diameter, which may cover up to 80% of total body area. These lesions may or may not be hairy. Smaller 'satellite' pigmented lesions numbering in the hundreds may also be present all over the body. Congenital melanocytic nevi (CMN) can be associated with malignant melanoma (see CMM1, 155600), but the risk appears to be low, ranging from 1 to 2% for all individuals, but rising to 10 to 15% in those with very large nevi (greater than 40 cm). A small subset of patients with CMNS have abnormalities of the central nervous system, known as 'neurocutaneous melanosis' or 'neuromelanosis' (249400), which may be symptomatic. Patients with CMNS also tend to have a characteristic facial appearance, including wide or prominent forehead, periorbital fullness, small short nose with narrow nasal bridge, round face, full cheeks, prominent premaxilla, and everted lower lip (summary by Kinsler et al., 2008; Kinsler et al., 2012). Spitz nevi are benign melanocytic melanomas composed of epithelioid or spindle cell melanocytes. They usually present as solitary skin tumors but can occur in multiple patterns, having agminated, dermatomal, and disseminated forms (summary by Sarin et al., 2013). Nevus spilus, also known as speckled lentiginous nevus, is a congenital hyperpigmented patch that progressively evolves, with affected individuals developing dark macules and papules during childhood and adolescence. Over time, nevus spilus may give rise to common lentigines, melanocytic nevi, Spitz nevi, and melanomas (summary by Sarin et al., 2014).
Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome
MedGen UID:
343465
Concept ID:
C1856053
Disease or Syndrome
MARCH is an autosomal recessive lethal congenital disorder characterized by severe hydranencephaly with almost complete absence of the cerebral hemispheres, which are replaced by fluid, relative preservation of the posterior fossa structures, and renal dysplasia or agenesis. Affected fetuses either die in utero or shortly after birth, and show arthrogryposis and features consistent with anhydramnios. Histologic examination of residual brain tissue shows multinucleated neurons resulting from impaired cytokinesis (summary by Frosk et al., 2017).
Autosomal recessive cutis laxa type 2B
MedGen UID:
414526
Concept ID:
C2751987
Disease or Syndrome
The phenotype of autosomal recessive cutis laxa type II (ARCL2) includes cutis laxa of variable severity, abnormal growth, developmental delay, and associated skeletal abnormalities (summary by Morava et al., 2009). No specific clinical features distinguish ARCL2A (219200), which includes a glycosylation defect, and ARCL2B, in which abnormal glycosylation has not been reported (Morava et al., 2009; Guernsey et al., 2009). For a phenotypic description and discussion of genetic heterogeneity of autosomal recessive cutis laxa, see ARCL1A (219100).
PYCR1-related de Barsy syndrome
MedGen UID:
482429
Concept ID:
C3280799
Disease or Syndrome
De Barsy syndrome, also known as autosomal recessive cutis laxa type III (ARCL3), is a rare autosomal recessive disorder characterized by an aged appearance with distinctive facial features, sparse hair, ophthalmologic abnormalities, intrauterine growth retardation (IUGR), and cutis laxa (summary by Lin et al., 2011). For a phenotypic description and a discussion of genetic heterogeneity of de Barsy syndrome, see 219150. For a phenotypic description and a discussion of genetic heterogeneity of autosomal recessive cutis laxa, see 219200.
Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome
MedGen UID:
813897
Concept ID:
C3807567
Disease or Syndrome
Lipodystrophies are rare disorders characterized by loss of body fat from various regions and predisposition to metabolic complications of insulin resistance and lipid abnormalities. FPLD7 is an autosomal dominant disorder with a highly variable phenotype. Additional features, including early-onset cataracts and later onset of spasticity of the lower limbs, have been noted in some patients (summary by Garg et al., 2015). For a general phenotypic description and a discussion of genetic heterogeneity of familial partial lipodystrophy (FPLD), see 151660.
Chromosome 22q13 duplication syndrome
MedGen UID:
816174
Concept ID:
C3809844
Disease or Syndrome
Progeroid and marfanoid aspect-lipodystrophy syndrome
MedGen UID:
934763
Concept ID:
C4310796
Disease or Syndrome
The marfanoid-progeroid-lipodystrophy syndrome (MFLS) is characterized by congenital lipodystrophy, premature birth with an accelerated linear growth disproportionate to weight gain, and progeroid appearance with distinct facial features, including proptosis, downslanting palpebral fissures, and retrognathia. Other characteristic features include arachnodactyly, digital hyperextensibility, myopia, dural ectasia, and normal psychomotor development (Takenouchi et al., 2013). Takenouchi et al. (2013) noted phenotypic overlap with Marfan syndrome (154700) and Shprintzen-Goldberg craniosynostosis syndrome (182212).
Galloway-Mowat syndrome 1
MedGen UID:
1634188
Concept ID:
C4551772
Disease or Syndrome
Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome
MedGen UID:
1675672
Concept ID:
C5193040
Disease or Syndrome
Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome is an autosomal recessive disorder with a highly variable phenotype. Although all patients have polymicrogyria and other variable structural brain anomalies on imaging, only some show developmental delay and/or seizures. Similarly, only some patients have connective tissue defects that particularly affect the vascular system and can result in early death (summary by Vandervore et al., 2017).
ALDH18A1-related de Barsy syndrome
MedGen UID:
1720006
Concept ID:
C5234852
Disease or Syndrome
De Barsy syndrome, or autosomal recessive cutis laxa type III (ARCL3), is characterized by cutis laxa, a progeria-like appearance, and ophthalmologic abnormalities (summary by Kivuva et al., 2008). For a phenotypic description and a discussion of genetic heterogeneity of autosomal recessive cutis laxa, see 219100. Genetic Heterogeneity of de Barsy Syndrome Also see ARCL3B (614438), caused by mutation in the PYCR1 gene (179035) on chromosome 17q25.
Mandibuloacral dysplasia with type A lipodystrophy
MedGen UID:
1757618
Concept ID:
C5399785
Disease or Syndrome
Mandibuloacral dysplasia with type A lipodystrophy (MADA) is an autosomal recessive disorder characterized by growth retardation, craniofacial anomalies with mandibular hypoplasia, skeletal abnormalities with progressive osteolysis of the distal phalanges and clavicles, and pigmentary skin changes. The lipodystrophy is characterized by a marked acral loss of fatty tissue with normal or increased fatty tissue in the neck and trunk. Some patients may show progeroid features. Metabolic complications can arise due to insulin resistance and diabetes (Young et al., 1971; Simha and Garg, 2002; summary by Garavelli et al., 2009). See also MAD type B (MADB; 608612), which is caused by mutation in the ZMPSTE24 gene (606480).
Mandibuloacral dysplasia progeroid syndrome
MedGen UID:
1741713
Concept ID:
C5436867
Disease or Syndrome
Mandibuloacral dysplasia progeroid syndrome (MDPS) is an autosomal recessive severe laminopathy-like disorder characterized by growth retardation, bone resorption, arterial calcification, renal glomerulosclerosis, and hypertension (Elouej et al., 2020).
Blepharophimosis-impaired intellectual development syndrome
MedGen UID:
1779966
Concept ID:
C5443984
Disease or Syndrome
Blepharophimosis-impaired intellectual development syndrome (BIS) is a congenital disorder characterized by a distinct facial appearance with blepharophimosis and global development delay. Affected individuals have delayed motor skills, sometimes with inability to walk, and impaired intellectual development with poor or absent speech; some patients show behavioral abnormalities. There are recognizable facial features, including epicanthal folds, sparse eyebrows, broad nasal bridge, short nose with downturned tip, and open mouth with thin upper lip. Other more variable features include distal skeletal anomalies, feeding difficulties with poor growth, respiratory infections, and hypotonia with peripheral spasticity (summary by Cappuccio et al., 2020).
Neurodevelopmental disorder with hypotonia and brain abnormalities
MedGen UID:
1794187
Concept ID:
C5561977
Disease or Syndrome
Neurodevelopmental disorder with hypotonia and brain abnormalities (NEDHYBA) is characterized by impaired development of motor skills, cognitive function, and speech acquisition beginning in infancy or early childhood. Some affected individuals may have feeding difficulties, seizures, behavioral abnormalities, and nonspecific dysmorphic facial features. Brain imaging shows variable abnormalities, including corpus callosum defects, cerebellar defects, and decreased white matter volume. There is significant phenotypic variability (summary by Duncan et al., 2021).
Restrictive dermopathy 1
MedGen UID:
1812447
Concept ID:
C5676878
Disease or Syndrome
A restrictive dermopathy that has material basis in homozygous or compound heterozygous mutation in the ZMPSTE24 gene on chromosome 1p34.
Liver disease, severe congenital
MedGen UID:
1823968
Concept ID:
C5774195
Disease or Syndrome
Severe congenital liver disease (SCOLIV) is an autosomal recessive disorder characterized by the onset of progressive hepatic dysfunction usually in the first years of life. Affected individuals show feeding difficulties with failure to thrive and features such as jaundice, hepatomegaly, and abdominal distension. Laboratory workup is consistent with hepatic insufficiency and may also show coagulation defects, anemia, or metabolic disturbances. Cirrhosis and hypernodularity are commonly observed on liver biopsy. Many patients die of liver failure in early childhood (Moreno Traspas et al., 2022).
Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects
MedGen UID:
1824008
Concept ID:
C5774235
Disease or Syndrome
Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects (NEDCDS) is characterized by global developmental delay, severely impaired intellectual development with poor or absent speech, characteristic facial features, and variable skeletal abnormalities. Additional features include feeding difficulties, inability to walk or walking with an abnormal gait, and cerebellar or other abnormalities on brain imaging (Reichert et al., 2020).
RECON progeroid syndrome
MedGen UID:
1841140
Concept ID:
C5830504
Disease or Syndrome
RECON progeroid syndrome (RECON) is a chromosomal instability disorder characterized by postnatal growth retardation, progeroid facial appearance, hypoplastic nose, prominent premaxilla, skin photosensitivity and xeroderma, muscle wasting with reduced subcutaneous fat, and slender elongated thumbs (Abu-Libdeh et al., 2022).

Professional guidelines

PubMed

Avila-Ortiz G, Bartold PM, Giannobile W, Katagiri W, Nares S, Rios H, Spagnoli D, Wikesjö UM
Int J Oral Maxillofac Implants 2016;31 Suppl:s121-64. doi: 10.11607/jomi.16suppl.g4. PMID: 27228246
Quelin C, Spaggiari E, Khung-Savatovsky S, Dupont C, Pasquier L, Loeuillet L, Jaillard S, Lucas J, Marcorelles P, Journel H, Pluquailec-Bilavarn K, Bazin A, Verloes A, Delezoide AL, Aboura A, Guimiot F
Am J Med Genet A 2014 Oct;164A(10):2504-9. Epub 2014 Jun 26 doi: 10.1002/ajmg.a.36658. PMID: 24975584

Recent clinical studies

Etiology

Calloway HE, Heilbronn CM, Gu JT, Pham TT, Barnes CH, Wong BJ
JAMA Facial Plast Surg 2019 Dec 1;21(6):558-565. doi: 10.1001/jamafacial.2019.1130. PMID: 31670749Free PMC Article
Dursun E, Keceli HG, Dolgun A, Velasco-Torres M, Olculer M, Ghoreishi R, Sinjab K, Sinacola RA, Kubilius M, Tözüm MD, Galindo-Moreno P, Yilmaz HG, Wang HL, Juodzbalys G, Tözüm TF
Implant Dent 2019 Jun;28(3):226-236. doi: 10.1097/ID.0000000000000862. PMID: 31124819
Sauerhammer TM, Patel K, Oh AK, Proctor MR, Mulliken JB, Rogers GF
J Craniofac Surg 2014 Mar;25(2):437-40. doi: 10.1097/01.scs.0000436674.59196.cd. PMID: 24448523
Hormozi AK, Shahverdiani R, Mohammadi HR, Zali A, Mofrad HR
J Craniofac Surg 2011 Jan;22(1):261-5. doi: 10.1097/SCS.0b013e3181f7b80c. PMID: 21233734
Mulliken JB, Burvin R, Padwa BL
Plast Reconstr Surg 2003 Mar;111(3):1000-10. doi: 10.1097/01.PRS.0000046244.08487.BF. PMID: 12621169

Diagnosis

Liu Y, Wang N, Xu J, Bi Y, Han X, Dai M, Liu C
Int J Immunopathol Pharmacol 2022 Jan-Dec;36:3946320221120962. doi: 10.1177/03946320221120962. PMID: 35968643Free PMC Article
Sauerhammer TM, Patel K, Oh AK, Proctor MR, Mulliken JB, Rogers GF
J Craniofac Surg 2014 Mar;25(2):437-40. doi: 10.1097/01.scs.0000436674.59196.cd. PMID: 24448523
Nowaczyk MJ, Tan M, Hamid JS, Allanson JE
Am J Med Genet A 2012 May;158A(5):1020-8. Epub 2012 Mar 21 doi: 10.1002/ajmg.a.35285. PMID: 22438180
Kinsler V, Shaw AC, Merks JH, Hennekam RC
Am J Med Genet A 2012 May;158A(5):1014-9. Epub 2012 Mar 21 doi: 10.1002/ajmg.a.34217. PMID: 22438093
Pierron S, Richelme C, Triolo V, Mas JC, Griffet J, Karmous-Benailly H, Quere M, Kaname T, Lambert JC, Giuliano F
Am J Med Genet A 2009 Aug;149A(8):1754-7. doi: 10.1002/ajmg.a.32910. PMID: 19606480

Therapy

Avila-Ortiz G, Bartold PM, Giannobile W, Katagiri W, Nares S, Rios H, Spagnoli D, Wikesjö UM
Int J Oral Maxillofac Implants 2016;31 Suppl:s121-64. doi: 10.11607/jomi.16suppl.g4. PMID: 27228246
Anitua E, Alkhraisat MH, Miguel-Sánchez A, Orive G
J Oral Maxillofac Surg 2014 Apr;72(4):683-93. Epub 2013 Dec 6 doi: 10.1016/j.joms.2013.11.022. PMID: 24635854
Mishima K, Sugahara T, Mori Y, Sakuda M
Cleft Palate Craniofac J 1996 Jul;33(4):312-7. doi: 10.1597/1545-1569_1996_033_0312_tdcbtp_2.3.co_2. PMID: 8827388
Ardinger HH, Atkin JF, Blackston RD, Elsas LJ, Clarren SK, Livingstone S, Flannery DB, Pellock JM, Harrod MJ, Lammer EJ
Am J Med Genet 1988 Jan;29(1):171-85. doi: 10.1002/ajmg.1320290123. PMID: 3125743
Yang TS, Chi CC, Tsai CJ, Chang MJ
Obstet Gynecol 1978 Dec;52(6):682-4. PMID: 733136

Prognosis

Anitua E, Alkhraisat MH, Miguel-Sánchez A, Orive G
J Oral Maxillofac Surg 2014 Apr;72(4):683-93. Epub 2013 Dec 6 doi: 10.1016/j.joms.2013.11.022. PMID: 24635854
Sauerhammer TM, Patel K, Oh AK, Proctor MR, Mulliken JB, Rogers GF
J Craniofac Surg 2014 Mar;25(2):437-40. doi: 10.1097/01.scs.0000436674.59196.cd. PMID: 24448523
Soardi CM, Spinato S, Zaffe D, Wang HL
Clin Oral Implants Res 2011 May;22(5):560-6. Epub 2010 Dec 9 doi: 10.1111/j.1600-0501.2010.02034.x. PMID: 21143532
González-García R, Monje F, Moreno C
Int J Oral Maxillofac Surg 2011 Jan;40(1):57-64. Epub 2010 Aug 21 doi: 10.1016/j.ijom.2010.03.030. PMID: 20729037
Schneider EN, Bogdanow A, Goodrich JT, Marion RW, Cohen MM Jr
Am J Med Genet 2000 Jul 17;93(2):89-93. doi: 10.1002/1096-8628(20000717)93:2<89::aid-ajmg2>3.0.co;2-4. PMID: 10869108

Clinical prediction guides

Eker HK
Childs Nerv Syst 2021 May;37(5):1779-1784. Epub 2020 Aug 18 doi: 10.1007/s00381-020-04843-9. PMID: 32809063
Calloway HE, Heilbronn CM, Gu JT, Pham TT, Barnes CH, Wong BJ
JAMA Facial Plast Surg 2019 Dec 1;21(6):558-565. doi: 10.1001/jamafacial.2019.1130. PMID: 31670749Free PMC Article
Avila-Ortiz G, Bartold PM, Giannobile W, Katagiri W, Nares S, Rios H, Spagnoli D, Wikesjö UM
Int J Oral Maxillofac Implants 2016;31 Suppl:s121-64. doi: 10.11607/jomi.16suppl.g4. PMID: 27228246
Sauerhammer TM, Patel K, Oh AK, Proctor MR, Mulliken JB, Rogers GF
J Craniofac Surg 2014 Mar;25(2):437-40. doi: 10.1097/01.scs.0000436674.59196.cd. PMID: 24448523
Kinsler V, Shaw AC, Merks JH, Hennekam RC
Am J Med Genet A 2012 May;158A(5):1014-9. Epub 2012 Mar 21 doi: 10.1002/ajmg.a.34217. PMID: 22438093

Recent systematic reviews

Avila-Ortiz G, Bartold PM, Giannobile W, Katagiri W, Nares S, Rios H, Spagnoli D, Wikesjö UM
Int J Oral Maxillofac Implants 2016;31 Suppl:s121-64. doi: 10.11607/jomi.16suppl.g4. PMID: 27228246

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...